89bio
ETNB
ETNB was delisted on the 29th of October, 2025.
69 hedge funds and large institutions have $64.3M invested in 89bio in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 4 closing their positions.
714% more call options, than puts
Call options by funds: $350K | Put options by funds: $43K
475% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 4
38% more funds holding
Funds holding: 50 → 69 (+19)
33% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 18
1.46% less ownership
Funds ownership: 85.33% → 83.87% (-1.5%)
72% less capital invested
Capital invested by funds: $226M → $64.3M (-$162M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$2.01M |
| 2 |
Renaissance Technologies
New York
|
+$1.7M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.16M |
| 4 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
+$1.15M |
| 5 |
Two Sigma Investments
New York
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$9.37M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.38M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$2.48M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.37M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.99M |
ETNB Hedge Fund Activity: Q1 2022 in Review
69 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in 89bio (ETNB) for Q1 2022, worth a combined $64.3M — down 72% from $226M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ETNB positions and 4 closed out — a net gain of 19 holders — while 24 added to existing stakes and 18 trimmed.
The largest buyer was Bank of America, adding an estimated $2.01M. The largest seller was Eventide Asset Management, exiting entirely with an estimated $9.37M sold.
- 69 institutional investors held 89bio (ETNB) as of Q1 2022, up from 50 in Q4 2021.
- Funds reported $64.3M of 89bio stock for Q1 2022, down 72% quarter-over-quarter.
- 23 funds opened new 89bio positions in Q1 2022 and 4 closed out, a net change of +19 holders.
- The largest 89bio buyer in Q1 2022 was Bank of America, an estimated $2.01M added.
- The largest 89bio seller in Q1 2022 was Eventide Asset Management, an estimated $9.37M sold.
Based on aggregated 13F filings for Q1 2022.